NCT05295316

Brief Summary

Fibromyalgia (FM) is a condition with a different non-specific symptoms which lead to a difficult diagnosis. Study suggests that osteopathy can help in improving FM symptoms, nevertheless, it can be difficult to identify which patients may benefit. The knowledge of FM risk factor can be useful tool for osteopaths and other clinician to implement a targeted, fast and multidisciplinary treatment protocol for those kind of patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 12, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 3, 2021

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 18, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 11, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 25, 2022

Completed
Last Updated

March 25, 2022

Status Verified

March 1, 2022

Enrollment Period

10 months

First QC Date

March 11, 2022

Last Update Submit

March 24, 2022

Conditions

Keywords

Osteopathy

Outcome Measures

Primary Outcomes (1)

  • Incidence of 29 stressing events

    The LSC-R questionnaire was used to evaluate the incidence of each stressor event

    1 year

Study Arms (2)

Fibromyalgia

FM group was recruited at AMaR (rheumatic patients association of Piedmont) and the diagnosis of primary fibromyalgia was confirmed by the referring rheumatologist of the AMaR association.

Other: Life Stressor Checklist Revised (LSC-R) (Appendix 1)

Control

The control group was recruited in the same geographic area as the FM participant. The general practitioner of each individual patient certified the subject's state of good health.

Other: Life Stressor Checklist Revised (LSC-R) (Appendix 1)

Interventions

Evaluation of stress factor as risk factor for fibromyalgia development

ControlFibromyalgia

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale women were used because have higher risk of fibromyalgia development.
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Female patients with or without fibromyalgia

You may qualify if:

  • female patients
  • Patient from Piedmont
  • age between 20 and 65 years old
  • inform consent
  • for case group primary or secondary fibromyalgia

You may not qualify if:

  • systemic or rheumatic or neoplastic diseases
  • for control group the presence of primary or secondary fibromyalgia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OsteoMedical

Novara, Italy

Location

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Carolina Lavazza, MSc

    Accademia Italiana Medicina Osteopatica

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Osteopath

Study Record Dates

First Submitted

March 11, 2022

First Posted

March 25, 2022

Study Start

April 12, 2020

Primary Completion

February 3, 2021

Study Completion

October 18, 2021

Last Updated

March 25, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations